United States · FDA National Drug Code directory
Rizatriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-087_fe80232a-c329-47ed-8edd-7786e06f3c08
- Product NDC
- 33342-087
- Form
- TABLET, FILM COATED
- Composition / generic term
- Rizatriptan
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140311
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 CONTAINER (33342-087-07) · 33342-087-07
- 10 BLISTER PACK in 1 CARTON (33342-087-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-087-12
- 3 BLISTER PACK in 1 CARTON (33342-087-41) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02) · 33342-087-41
- 2 BLISTER PACK in 1 CARTON (33342-087-45) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02) · 33342-087-45
- 200 TABLET, FILM COATED in 1 CONTAINER (33342-087-46) · 33342-087-46
- 4 BLISTER PACK in 1 CARTON (33342-087-50) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52) · 33342-087-50
- 6 BLISTER PACK in 1 CARTON (33342-087-72) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52) · 33342-087-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →